CROs/Service Providers

Novella Clinical, Cardiovascular Research Foundation collaborate, provide clinical trial expertise

Monday, January 12, 2015 02:37 PM

Novella Clinical, a Quintiles company, and the Cardiovascular Research Foundation (CRF), an independent, academically focused nonprofit organization based in New York, have announced a preferred provider collaboration that will offer a set of clinical trial services to developers of cardiovascular drugs and devices.

More... »

Theorem Clinical Research

AMRI to acquire Aptuit drug development, aseptic manufacturing businesses

Friday, January 9, 2015 02:01 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has acquired the outstanding equity interests of Aptuit's Glasgow, U.K., business and has entered into a definitive agreement to acquire Aptuit's SSCI/West Lafayette, Ind., business, for a total of $60 million, expanding AMRI's drug product development and aseptic clinical manufacturing capabilities.

More... »

Quest Diagnostics

WuXi PharmaTech acquires NextCODE Health

Friday, January 9, 2015 01:58 PM

WuXi PharmaTech, an open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries with operations in China and the U.S., has acquired NextCODE Health, a genomic analysis and bioinformatics company with operations in the U.S. and Iceland, for $65 million in cash.

More... »

Clinical Network Services establishes U.S. operations

Thursday, January 8, 2015 12:57 PM

Clinical Network Services (CNS), an integrated product development company based in Australia, New Zealand and the U.K., providing planning, implementation and delivery of preclinical through phase II trials, has established an office in the U.S. CNS also has appointed Megan Hill business development manager in the U.S.

More... »

CRF Health gains private equity investment, new majority shareholder, to help fuel expansion

Thursday, January 8, 2015 12:52 PM

CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, has announced a significant investment of funds managed and advised by Vitruvian Partners, a London-based private equity firm, subject only to customary regulatory approvals.

More... »

Certara’s Synchrogenix acquires ClinGenuity

Wednesday, January 7, 2015 12:57 PM

Synchrogenix, the regulatory and medical consultancy of Certara, a Princeton, N.J.-based global biosimulation technology-enabled drug development and drug safety consulting company, has acquired ClinGenuity, a Cincinnati-based artificial intelligence-assisted medical writing service. Their combined team now will include more than 200 regulatory and medical writers with experience in document development for the FDAEMA and other global regulatory organizations.

More... »

Sciformix expands, adds new office in the U.K.

Wednesday, January 7, 2015 12:56 PM

Sciformix, a scientific process organization (SPO) located in Westborough, Mass., has opened a new office in Manchester, U.K., expanding its global presence and footprint to include the European region. Sciformix supports life science organizations with high quality services in safety and risk management, regulatory affairs and operations and clinical research and post-approval support.

More... »

Date set for arbitration trial between CEL-SCI and inVentiv

Wednesday, January 7, 2015 12:45 PM

CEL-SCI, a biotechnology company based in Vienna, Va., has announced that the trial in its ongoing arbitration against CRO inVentiv Clinical currently is scheduled for May 4.

More... »

Mapi completes acquisition of Optum Life Sciences services

Tuesday, January 6, 2015 08:00 AM

Mapi, a global health research and commercialization services company, has completed the acquisition of select Optum Life Sciences services, including North American and European Regulatory Consulting, Late Phase CRO and European Health Economics and Outcomes Research (HEOR) teams.

More... »

UPS to acquire Polish healthcare logistics company Poltraf

Monday, January 5, 2015 12:51 PM

UPS has agreed to terms with Poland-based investment fund ORTIE to acquire its pharmaceutical logistics company Poltraf. The acquisition will further strengthen UPS' healthcare experience and network in Europe, enabling compliant logistics services to customers for streamlining their product supply to the fast-growing healthcare markets of Central and Eastern Europe.

More... »


March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs